{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:22:31Z","timestamp":1785370951459,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2020,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/modpathol.2017.19","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T08:42:29Z","timestamp":1490344949000},"page":"940-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["3q26.2\/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms"],"prefix":"10.1016","volume":"30","author":[{"given":"Zhihong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Hodjat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.19_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","article-title":"Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2017.19_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.critrevonc.2015.11.004","article-title":"Myeloproliferative neoplasms: current molecular biology and genetics","volume":"98","author":"Saeidi","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/modpathol.2017.19_bib3","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"31","article-title":"Myeloproliferative neoplasms","author":"Thiele","year":"2008"},{"key":"10.1038\/modpathol.2017.19_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: a contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2017.19_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.29842","article-title":"The evolution and clinical relevance of prognostic classification systems in myelofibrosis","volume":"122","author":"Bose","year":"2016","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2017.19_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1412098","article-title":"Effect of mutation order on myeloproliferative neoplasms","volume":"372","author":"Ortmann","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2017.19_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1309\/AJCP48AJDCKTHUXC","article-title":"Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia","volume":"136","author":"Cui","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.19_bib8","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms","volume":"123","author":"Lundberg","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3324\/haematol.2013.096420","article-title":"Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)\/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study","volume":"99","author":"Rogers","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.19_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/modpathol.2010.210","article-title":"De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification","volume":"24","author":"Sun","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.19_bib11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2015-05-646489","article-title":"Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib12","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2016-01-690230","article-title":"Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy","volume":"127","author":"Wang","year":"2016","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.2017.19_bib14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/fon.15.64","article-title":"3q26.2\/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review","volume":"11","author":"De Braekeleer","year":"2015","journal-title":"Future Oncol"},{"key":"10.1038\/modpathol.2017.19_bib15","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/sj.leu.2400880","article-title":"The EVI1 gene in myeloid leukemia","volume":"11","author":"Nucifora","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.19_bib16","first-page":"141","article-title":"Identification of 3q21q26.2 syndrome by \"multipoint\" interphase FISH analyses in childhood myeloid leukemia","volume":"49","author":"Haltrich","year":"2005","journal-title":"Magy Onkol"},{"key":"10.1038\/modpathol.2017.19_bib17","series-title":"An international system for human cytogenetic nomenclature (ISCN 2013), recommendations of the international standing commitee on human cytogenetic nomenclature","author":"Shaffer","year":"2016"},{"key":"10.1038\/modpathol.2017.19_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status","volume":"29","author":"Gangat","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2017.19_bib19","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/sj.emboj.7600679","article-title":"Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression","volume":"24","author":"Yuasa","year":"2005","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2017.19_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.leu.2400584","article-title":"The leukemia-associated gene MDS1\/EVI1 is a new type of GATA-binding transactivator","volume":"11","author":"Soderholm","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.19_bib21","first-page":"564","article-title":"Fusion of ETV6 to MDS1\/EVI1 as a result of t(3;12)(q26.2;p13) in myeloproliferative disorders","volume":"57","author":"Peeters","year":"1997","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.19_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","article-title":"A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia","volume":"157","author":"Groschel","year":"2014","journal-title":"Cell"},{"key":"10.1038\/modpathol.2017.19_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2017.19_bib24","first-page":"1318","article-title":"Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)","volume":"8","author":"Fonatsch","year":"1994","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.19_bib25","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1182\/blood-2012-10-464248","article-title":"Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms","volume":"121","author":"Kennedy","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2014-07-591461","article-title":"Mutational spectrum of myeloid malignancies with inv(3)\/t(3;3) reveals a predominant involvement of RAS\/RTK signaling pathways","volume":"125","author":"Groschel","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood-2014-07-591529","article-title":"EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations","volume":"125","author":"Lavallee","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib29","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1182\/blood-2008-09-178541","article-title":"The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course","volume":"113","author":"Tam","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.19_bib30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201719","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200775X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200775X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:39:40Z","timestamp":1760229580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522200775X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S089339522200775X"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.19","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3q26.2\/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.19","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}